INTRODUCTION
Oxidative stress is a common feature of a diverse range of neuropathological conditions, including stroke, Parkinson's Disease, Alzheimer's Disease, and Amyotrophic Lateral Sclerosis (1, 2) . Glutamate-induced oxidative toxicity provides an excellent model for studying the effects of oxidative stress in immortalized neurons and in primary neuronal cultures (3, 4, 5) . In this model, inhibition of a glutamate/cystine antiporter, known as system x c -, leads to decreased accumulation of intracellular free cysteine, a necessary precursor of glutathione, and to eventual glutathione depletion. As a result, reactive oxygen species (ROS) accumulate and activate cellular signaling events that contribute to neuronal cell death. We have previously shown that oxidative toxicity causes a delayed, sustained stress consistent with a mechanism involving the oxidation of cysteine thiols. This inhibition of ERK-directed phosphatases correlates with an increase in phosphorylated ERK levels. We
show that this aggregate phosphatase activity is likely comprised of PP2A and a vanadatesensitive component. The impact of ERK-directed phosphatase activity on oxidative toxicity was revealed by the neuroprotective effects of overexpressed mitogen-activated protein kinase phosphatase 3 (MKP3) and its catalytic mutant, MKP3 C293S, in both HT22 cells and primary cortical neurons. Collectively, these data implicate oxidative inhibition of ERKdirected phosphatases in neuronal oxidative toxicity induced by glutathione depletion.
EXPERIMENTAL PROCEDURES
Plasmids The expression plasmids for MKP3 WT and MKP3 C293S, as well as the parent plasmid (pSG5), were kind gifts from Dr. Steven Keyse and Dr. Anne Brunet (19, 20, 21) .
The mitochondria-targeted eYFP expression plasmid was a gift from Dr. Ian Reynolds, and the expression plasmid for the Elk-1/GAL4 fusion protein, the luciferase reporter, and the constitutive renilla plasmid (all from Strategene, La Jolla, CA) were purchased or donated by Dr. Elias Aizenman. Cells were counted and plated on 50 µg/ml poly-D-lysine treated culture plates at a density of ~2.1 x 10 4 cells / cm 2 . Cell viability was routinely greater than 80% as assessed by uptake of trypan blue dye upon plating. Cultures were maintained for 3-4 days in media (DME (Invitrogen), 10% FCS (Hyclone, Logan, UT), 10% Ham's F12 Nutrient Supplement (Invitrogen), 1.9 mM glutamine, 24 mM Hepes Buffer, and 4.5 mg/mL glucose) at 37 º C and 5% CO 2 . At this time, these mixed cortical cultures are predominately neuronal, with approximately 20% glial fibrillary associated protein (GFAP) staining cells (3) . Unless otherwise stated, all chemicals and reagents used were purchased from Sigma Chemical Corporation, St. Louis, MO.
Primary Cortical Cultures
Cell Line Culture HT22 cells, a hippocampal cell line that is sensitive to glutamate-induced oxidative toxicity (5), were maintained in DME supplemented with 10% FCS (Atlanta Biologicals, Norcross, GA), 100 Units Penicillin, and 100 µg/mL Streptomycin at 37ºC and 5% CO 2 .
Transfections in Primary Cortical
Neuronal Cultures A number of transfection reagents and protocols that were tested proved toxic to our primary immature cortical cultures. However, limited toxicity was observed when the 25 kD polyamine polymer poly(ethyleneimine) (PEI) was used to form DNA-complexes and to transfect primary neurons (22, 23) . In brief, 2 µL of a 100 mM PEI stock solution was added to 250 µL 150 mM NaCl, while 6.5 µg of DNA was added to 250 µL 150 mM NaCl. Two µg of a mitochondria-targeted enhanced YFP (mteYFP) plasmid DNA and 4.5 µg of MKP3 plasmids were used per condition. After 5 min, the two solutions were mixed. PEI/DNA complexes were allowed to form for 10 min, and then diluted into 10 mL MEM (Invitrogen). Conditioned media was removed from the primary neuronal cultures and replaced with MEM. One mL of transfection solution was added to each 35 mm well and left to incubate at 37ºC for 1 hr. The transfection media was then removed and replaced with conditioned media for the remainder of the experiment. The transfection efficiency with this method varied between 0.1 -0.5 %. Glutamate treatment was initiated 24 hrs following transfection. After 90 min of rocking at 4ºC, the samples were washed twice with wash buffer and once in 300 mM NaCl, 25 mM Tris, pH 7.5. The beads were then suspended in NaCl/Tris and Laemmli buffer, boiled for 5 min, loaded onto a 10% polyacrylamide gel, transferred to polyvinylidine fluoride (PVDF) membranes (Millipore, Bedford, MA), and subjected to Western Blotting to detect phosphorylated ERK and total ERK (see below).
Transfections in HT22 cells

JNK-directed Phosphatase Activity Assay
This method was performed exactly as described above, except that each sample was incubated with 30 ng of purified, dually-phosphorylated His 6 -tagged JNK-1 protein (Upstate, Waltham, MA), and Western blots were probed with anti-phospho JNK and total-JNK antibodies.
Western Blot Analysis Cells were treated as described, scraped and collected into PBS, pelleted at 3000 rpm for 5 min, and resuspended in Lysis Buffer (50mM Tris-Cl, pH 7.5, 2mM EDTA, 100 mM NaCl, 1% NP-40, 100µM Na 3 VO4, 100 µM NaF, 2mM DTT)
supplemented with 5µL protease inhibitor cocktail (Sigma) per mL of lysis buffer. Total extract protein concentrations were determined using the Bio-Rad ™ reagent. Equivalent amounts of total protein (either 15 or 20 µg) were separated by SDS-PAGE on 10%
polyacrylamide gels and then transferred to PVDF membranes (Millipore, Bedford, MA).
Membranes were blocked with 5% dry milk in PBS / 0.1% v/v Tween-20 (PBST).
Membranes were then incubated with primary antibodies (anti-phospho ERK, anti-total ERK, anti-phospho JNK, anti-total JNK, or anti-c-myc, all from Cell Signaling) overnight at 4ºC with 3% dry milk or 5% BSA, washed 3x 10 min with PBST, and then exposed to the significant, and all data was analyzed using GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego California USA).
RESULTS
ERK-Directed Phosphatase Activity is Specifically Inhibited during Glutamate-Induced Oxidative Toxicity in Primary Immature Cortical Cultures
We have previously reported that in primary immature cortical cultures, ERK1/2 phosphorylation is elevated during oxidative stress generated by glutamate-induced glutathione depletion (6, 8) . Given the sensitivity of some protein phosphatases to cellular redox state (15), we set out to examine whether ERK-directed phosphatase activity was altered during glutamate-induced oxidative toxicity. Toward this end, we adapted a novel in vitro phosphatase assay that uses whole cell lysates to dephosphorylate purified dually- Figure 1A ). Indeed, DTT treatment of lysates from primary cortical neuronal cultures not exposed to glutamate led to increased ERK-directed phosphatase activity (data not shown). Thus, a small pool of ERK-phosphatases may be normally under tonic, reversible oxidative inhibition in primary neurons, despite intracellular conditions that are generally reducing.
To determine the substrate specificity of the phosphatase activity affected by oxidative stress, we assayed the activity of c-jun N-terminal kinase (JNK)-directed phosphatases using purified His 6 -tagged dually phosphorylated JNK1 protein in the same primary neuron lysates used to monitor ERK dephosphorylation. As shown in Figure 1C , JNK1-directed phosphatase activity is not significantly altered during glutamate-induced oxidative toxicity.
Furthermore, the addition of 50 mM DTT did not enhance JNK-phosphatase activity in the lysates ( Figure 1C , compare lanes 3 and 7), unlike the restoration of ERK-directed phosphatase activity by DTT in the same lysates. However, these extracts do contain some active JNK-phosphatases, as phosphorylated JNK levels were reduced upon incubation with extracts as compared to input (compare lanes 1 and 3, Figure 1C ). To examine the phosphorylation state of endogenous JNK1 (p46) and JNK2/3 (p54) in the primary neurons,
we performed Western Blot analysis using a phospho-specific JNK antibody. As can be seen in Figure 1D , JNK phosphorylation does not change during glutamate-induced oxidative toxicity, even during times of increased oxidative stress (i.e. 12-14 hours after the addition of glutamate). This finding is consistent with the lack of regulation of JNK-phosphatase activity by oxidative stress. Thus, oxidative stress in immature cortical neuron cultures specifically inhibits the activity of a subset of phosphatases that act upon specific mitogenactivated protein kinase (MAPK) members. Furthermore, the selectivity of oxidative inhibition of MAPK-directed phosphatases revealed in the in vitro assay correlates with the specificity of MAPK activation in oxidatively stressed neurons.
ERK-Directed Phosphatase Activity Can be Inhibited by Okadaic Acid and Orthovanadate
In order to ascertain the contribution of tyrosine/dual-specificity versus serine/threoninedirected phosphatases to ERK dephosphorylation in primary neuron cultures, we utilized two inhibitors: okadaic acid (OA) and sodium orthovanadate. OA is a well characterized serine/threonine directed protein phosphatase inhibitor with a high degree of selectivity at low concentrations for PP2A. Furthermore, a major component of ERK-phosphatase activity in neurons is contributed by PP2A (25) . As shown in Figure 2A , treatment with either 0.1 µM or 1.0 µM OA led to near complete inhibition of ERK-directed phosphatase activity in lysates from untreated control cultures (compare lanes 4 and 5 to lane 3, Figure 2A ). Thus, our in vitro assay confirms the expected contribution of PP2A to ERK-dephosphorylation in neurons.
Sodium orthovanadate is a potent inhibitor of tyrosine-and dual-specificity phosphatases that does not affect serine/threonine-directed phosphatases. Currently, there are few compounds available that inhibit specific tyrosine-or dual-specificity phosphatases, yet orthovanadate remains a useful tool to delineate the contribution of these classes of phosphatases to the regulation of protein phosphorylation. To examine the role of tyrosineand dual-specificity phosphatases to the observed phosphatase activity in untreated neuronal cultures, we treated lysates from these untreated cells with 1 mM Na 3 VO 4 . As is shown in Figure 2B and 2C, orthovanadate significantly inhibited ERK-directed phosphatase activity in lysates from untreated cultures. Importantly, the degree of inhibition observed with orthovanadate was less than that observed with OA, further confirming the predominant role of PP2A as an ERK-directed phosphatase activity in neurons. Nonetheless, tyrosine-and/or dual-specificity phosphatases appear to operate in primary neurons as ERK-directed phosphatases. 
The Reversibly Oxidized Pool of ERK-Directed
Overexpression of MKP3 WT and MKP3 C293S significantly alters ERK Phosphorylation
and Translocation in HT22 Cells. The extent of reversible inhibition of ERK-directed phosphatases generated by glutamate treatment of cells (Fig. 1A) is much less than that observed upon pharmacological inhibition of phosphatase activity in vitro ( Fig. 2A) . Thus, it is conceivable that sufficient overexpression of a specific phosphatase or associated factor could overcome the effects of oxidative stress on endogenous phosphatase activity and reduce ERK phosphorylation. The robust inhibitory effect of OA on ERK-directed phosphatase activity in primary neuron extracts highlights PP2A as a logical candidate for overexpression analysis. Although PP2A exists as a multimeric complex in vivo, expression of the catalytic subunit alone (i.e. C subunit) can be sufficient for activity (26) . However, manipulation of PP2A activity in vivo upon catalytic subunit overexpression is complicated by the auto-inactivation of PP2A activity that results from C subunit overexpression (26, 27 ).
Furthermore, PP2A has a wide range of substrates other than ERK1/2, making it difficult to ascribe biological effects of PP2A activity manipulation to effects on a particular substrate (i.e. ERK1/2).
We therefore decided to assess the effects on glutamate toxicity resulting from the overexpression of a single subunit ERK-directed phosphatase. MKP3 is a dual-specificity phosphatase with a high degree of selectivity toward ERK1/2 that is predominantly localized in the cytoplasm (28 and therefore functions as a dominant negative to limit the access of endogenous ERK1/2 to endogenous phosphatases. Furthermore, the C293S mutant of MKP3 can be used to assess the impact of nuclear localization of active ERK1/2 as its overexpression leads to the trapping of active, phosphorylated ERK1/2 in the cytoplasm (21).
As expected from previous analyses of MKP3 compartmentalization, MKP3 WT and Given that Elk-1 is an established nuclear target of ERK, enhanced transactivation activity resulting from its phosphorylation by nuclear localized ERK is easily monitored through the activity of the luciferase reporter in this system.
As confirmation of the sensitivity of this system to the presence of activated ERK in the nucleus, luciferase activity was induced nearly two-fold upon glutamate treatment of HT22 cells transfected with an empty vector ( Figure 4E ). Treatment with the MEK inhibitor, U0126, blocked the glutamate-induced increase in luciferase activity. As shown in Figure   4E , MKP3 WT overexpression reduced luciferase expression below baseline in both untreated and glutamate-treated cells, as would be expected from the dramatic reduction in ERK phosphorylation ( Figure 4A , lanes 2 and 5). Interestingly, MKP3 C293S overexpression, which led to a significant increase in ERK phosphorylation ( Figure 4A , lanes ( Figure 4E) . This result again confirms the sensitivity of the system to detect the activity of phosphorylated ERK within the nucleus and establishes the ability of MKP3 C293S to restrict nuclear translocation of active ERK in a neuronal cell line, consistent with previous work in fibroblast cell lines (21) . Collectively, these data show that glutamate-induced oxidative toxicity in HT22 cells is indeed accompanied by a functional increase in ERK signaling in the nucleus.
Overexpression of MKP3 WT and MKP3 C293S Protects both HT22 Cells and Primary
Immature Cortical Neurons from Glutamate-Inducted Oxidative Toxicity Given that MKP3
WT and MKP3 C293S overexpression was effective in manipulating both ERK activation and translocation, we sought to determine their impact on glutamate-induced oxidative- C293S significantly protected both HT22 cells and primary neurons from cell death implies that activation of ERK1/2 alone is not sufficient to induce toxicity in response to glutathione depletion. Active ERK1/2 must be capable of translocating to the nucleus in order to trigger cell death in oxidatively stressed neurons.
DISCUSSION
Although thiol-oxidation and inactivation of phosphatases has been shown in numerous cellular systems to be a feature of normal cellular signaling events (15) and to occur during ROS accumulation in neuronal cell lines (30) , the role of this mechanism in oxidative stressinduced neurotoxicity has not been assessed previously. In this report, ERK-directed phosphatase activity was found to be specifically inhibited during times of oxidative stress, while phosphatases regulating other MAPKs, such as JNK1, were not affected. This inhibition of ERK-directed phosphatase activity is coincident with the temporal pattern of ERK activation that occurs during glutamate-induced oxidative toxicity -only at times in which inhibition of ERK-directed phosphatase activity is detected do we observe a concurrent increase in phosphorylated ERK1/2. These findings of substrate specificity and temporal congruence strongly indicate that oxidative inhibition of ERK-directed phosphatase activity is a mechanism that drives ERK activation and propels neurons toward a cell-death pathway. Based upon inhibitor studies, PP2A and vanadate-sensitive phosphatases appear to be the likely phosphatases that mediate this effect.
Many studies have demonstrated p38 and JNK activation during oxidative stress in numerous cell types, including primary cortical neuronal cultures (31, 32) . We do not observe JNK or p38 activation in either HT22 cells or primary immature cortical neuronal cultures during glutatamte-induced oxidative toxicity. A potential reason for this disparity could be attributed to differences in the complement of MAPK-directed phosphatases that are expressed in various cellular systems or to the specificity to which certain phosphatases, even within one cell type, may be inhibited by oxidative stress. We have shown that JNK-directed phosphatases are not inhibited by oxidative stress in primary cortical cultures, and that this correlates with the lack of increased JNK phosphorylation during oxidative stress. Thus JNK-directed MAPK phosphatases, such as M3/6, may not be as sensitive to oxidation as ERK-directed phosphatases, such as MKP3 or STEP. Further work clearly needs to be done to determine the differential sensitivities of various phosphatases to oxidation, as this has a direct implication for potential mechanisms of oxidative signaling.
A number of mechanisms could account for oxidation-dependent phosphatase inhibition.
Protein-tyrosine phosphatases exhibit sensitivity toward oxidation of the catalytic cysteine (33) , and inactivation can occur by both reversible and irreversible mechanisms. Because both tyrosine-directed and dual-specificity phosphatases share a canonical HC(X) 5 R motif in their active sites, it is likely that both classes undergo similar mechanisms of inhibition.
Conversion of the active-site cysteine to a metastable sulfenic acid (Cys-SOH) (15) However, the extent to which this mechanism operates in other phosphatases is currently unknown. Progression of these reversible states to sulfinic (Cys-SO 2 H) or sulfonic (Cys-SO 3 H) acid forms leads to irreversible phosphatase inhibition. Since we observe total reversibility of oxidative phosphatase inhibition with the thiol-reductant DTT, oxidation of ERK-directed phosphatases to sulfinic and sulfonic forms are unlikely to occur in the oxidatively stressed neuronal cultures that we analyzed. Furthermore, the fact that activity is recoverable with DTT rules out the possibility that decreased ERK-directed phosphatase activity during oxidative stress reflects decreased phosphatase expression (36) or increased phosphatase degradation (37) . The restoration of ERK-directed phosphatase activity with DTT is likely to represent a direct effect on the phosphatases themselves. However, it is formally possible that DTT is reversing the thiol-oxidation of cofactors necessary for ERKdirected phosphatase function. The identification of both the sites of oxidation and the mechanism of inhibition of specific ERK-directed phosphatases during oxidative stress will be the subject of future studies. Amyotrophic Lateral Sclerosis patients due to an effect thought to be mediated by oxidation (38) . Indeed, it has been known for some time that PP2A activity is reduced in the cortices of Alzheimer's patients as compared to control patients (39) , and ERK has been found to be activated in these tissues (40) . Tau is a well-described ERK1/2 target (41) Because the endogenous pool of PP2A and vanadate-sensitive phosphatases is inactivated during oxidative toxicity in primary neurons, we sought to overexpress one of these phosphatases to attempt to overcome this inhibition and impact ERK activation. The choice of MKP3 as a tool to manipulate ERK activity in our system was made for several reasons.
MKP3 is localized in the cytoplasm and physically interacts with ERK1/2 at a kinaseinteracting motif (KIM) domain in its N-terminus in a highly specific manner. Brunet et al.
elegantly showed that the overexpression of MKP3 WT could extinguish ERK1/2 signaling, whereas overexpression of the catalytic mutant, MKP3 C293S, could abolish ERK1/2 signaling specifically in the nucleus by acting to trap activated ERK1/2 in the cytoplasm via its physical interaction with the KIM domain of the MKP3 C293S protein (21) . Interestingly, MKP3 C293S was not shown to impair ERK1/2 functioning in the cytoplasm (21) . ERK activation occurs downstream of ROS production in primary immature cortical cultures undergoing glutamate-induced oxidative toxicity. We have previously monitored ROS in primary immature cortical cultures, and ERK inhibition via U0126 administration did not alter the rate or extent of ROS production in these cells during glutamate-induced oxidative toxicity (8) . We observe that ERK-directed phosphatases are still inhibited in glutamate-induced oxidative toxicity in the presence of U0126 (data not shown), a treatment that protects these cultures from cell death. This indicates that the ERK-directed phosphatase inhibition is not sufficient for toxicity in of itself, but must act through specific activation of ERK. Furthermore, it also implies that there is a requirement for MEK activity to provide a forward drive for ERK activation during oxidative stress in primary immature cortical
The results reported here represent the first demonstration of the critical toxic role of ERK1/2 activity in the nucleus using a molecular approach rather than relying upon inhibitor studies, which can not resolve the distinction between ERK1/2 activation as a whole versus the nuclear translocation of active ERK1/2. Thus, the spatio-temporal pattern of ERK activation during glutamate-induced oxidative toxicity is critical for determining the cellular response to this insult, and nuclear targets of ERK must be mobilized to bring about oxidative toxicity in neurons. We also have implicated an intriguing mechanism by which oxidative stress may be coupled to ERK activation. Specific oxidation of ERK-directed phosphatases during glutamate-induced oxidative toxicity could drive ERK activation and nuclear accumulation, leading to neuronal cell death. We are now fully engaged in determining the specific phosphatases that are involved in mediating this effect and the mechanism by which they are inhibited by oxidative stress. found to be statistically significant (C). Because orthovanadate led to less inhibition of ERKdirected phosphatase activity than okadaic acid, it is likely that both tyrosine-directed and dual-specificity phosphatases contribute to this activity, while PP2A is the major component.
All experiments were conducted at least 4 times. * = p < 0.05; I = phosphatase assay input; ?
= lambda phage protein phosphatase (positive control); C=lysates from control cultures. 
